Literature DB >> 18484665

A new pathologic mitochondrial DNA mutation in the cytochrome oxidase subunit I (MT-CO1).

María D Herrero-Martín1, Mercedes Pineda, Paz Briones, Ester López-Gallardo, Magdalena Carreras, Mercedes Benac, Miguel Angel Idoate, María A Vilaseca, Rafael Artuch, Manuel J López-Pérez, Eduardo Ruiz-Pesini, Julio Montoya.   

Abstract

A disorder of mitochondrial energy metabolism may be missed in children with a very mild phenotype. Here, we described a patient with a moderate mental retardation and a mild exercise intolerance. This child harboured a mtDNA transition (m.6955G>A) in the subunit I of the cytochrome oxidase (MT-CO1) that fulfils most of the requirements to be pathologic. Despite this subunit is the second longest polypeptide encoded in the mtDNA, only one other missense mutation associated with a myopathy has been described. This suggests that we are missing other phenotypes and that the mitochondrial pathology field is broader that previously thought.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484665     DOI: 10.1002/humu.20800

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  Detection of novel mitochondrial mutations in cytochrome C oxidase subunit 1 (COX1) in patients with familial adenomatous polyposis (FAP).

Authors:  E Afkhami; M M Heidari; M Khatami; F Ghadamyari; S Dianatpour
Journal:  Clin Transl Oncol       Date:  2019-09-24       Impact factor: 3.405

2.  Autism and intellectual disability associated with mitochondrial disease and hyperlactacidemia.

Authors:  José Guevara-Campos; Lucía González-Guevara; Omar Cauli
Journal:  Int J Mol Sci       Date:  2015-02-11       Impact factor: 5.923

3.  A census of P. longum's phytochemicals and their network pharmacological evaluation for identifying novel drug-like molecules against various diseases, with a special focus on neurological disorders.

Authors:  Neha Choudhary; Vikram Singh
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

4.  Pharmacologic concentrations of linezolid modify oxidative phosphorylation function and adipocyte secretome.

Authors:  Laura Llobet; M Pilar Bayona-Bafaluy; David Pacheu-Grau; Elena Torres-Pérez; José M Arbones-Mainar; M Ángeles Navarro; Covadonga Gómez-Díaz; Julio Montoya; Ester López-Gallardo; Eduardo Ruiz-Pesini
Journal:  Redox Biol       Date:  2017-05-31       Impact factor: 11.799

Review 5.  An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases.

Authors:  Federica Marra; Paola Lunetti; Rosita Curcio; Francesco Massimo Lasorsa; Loredana Capobianco; Vito Porcelli; Vincenza Dolce; Giuseppe Fiermonte; Pasquale Scarcia
Journal:  Biomolecules       Date:  2021-11-04

6.  Structural analysis of mitochondrial mutations reveals a role for bigenomic protein interactions in human disease.

Authors:  Rhiannon E Lloyd; John E McGeehan
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

7.  Association Analysis of Single-Cell RNA Sequencing and Proteomics Reveals a Vital Role of Ca2+ Signaling in the Determination of Skeletal Muscle Development Potential.

Authors:  Kai Qiu; Doudou Xu; Liqi Wang; Xin Zhang; Ning Jiao; Lu Gong; Jingdong Yin
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

8.  Leigh Syndrome in a Pedigree Harboring the m.1555A>G Mutation in the Mitochondrial 12S rRNA.

Authors:  Mouna Habbane; Laura Llobet; M Pilar Bayona-Bafaluy; José E Bárcena; Leticia Ceberio; Covadonga Gómez-Díaz; Laura Gort; Rafael Artuch; Julio Montoya; Eduardo Ruiz-Pesini
Journal:  Genes (Basel)       Date:  2020-08-27       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.